Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin.
De Turck
B J
BJ
Diltoer
M W
MW
Cornelis
P J
PJ
Maes
V
V
Spapen
H D
HD
Camu
F
F
Huyghens
L P
LP
D000368:Aged; D000583:Amikacin / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000097:blood*; D004336:Drug Antagonism; D005260:Female; D006801:Humans; D000077731:Meropenem; D008875:Middle Aged; D013845:Thienamycins / Q000009:adverse effects*; D014635:Valproic Acid / Q000097:blood*
D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D013845:Thienamycins; D014635:Valproic Acid; D000583:Amikacin; D000077731:Meropenem